IP Library Patent Application 18575265
Patent Application
App. No. 18/575,265

DNA ORIGAMI STRUCTURE AND PROTEIN NANOPORE CONSTRUCT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/575,265
Abstract

The present application discloses a novel DNA origami structure and a nanopore construct associated with the DNA origami structure. The DNA origami structure includes a first hydrophilic section at a first end of the DNA origami structure, a stopper section adjacent the first hydrophilic section, a second hydrophilic section at a second end of the DNA origami structure, a hydrophobic section between the stopper section and the second hydrophilic section, and an open cavity running through the DNA origami structure from the first end to the second end. The stopper section is configured to lay against the membrane when the DNA origami structure is inserted through the membrane.

Claims (31)

1 . A DNA origami structure for insertion through a membrane, wherein the DNA origami structure comprises:

a first hydrophilic section at a first end of the DNA origami structure;

a stopper section adjacent the first hydrophilic section, wherein the stopper section is configured to lay against the membrane when the DNA origami structure is inserted through the membrane;

a second hydrophilic section at a second end of the DNA origami structure;

a hydrophobic section between the stopper section and the second hydrophilic section; and

an open cavity running through the DNA origami structure from the first end to the second end.

2 . The DNA origami structure of claim 1 , further comprising one or more hydrophobic moieties attached to a bottom portion of the stopper section facing the second end.

3 . The DNA origami structure of claim 2 , wherein each hydrophobic moiety is covalently attached to a first single-stranded DNA that is hybridized with a first single-stranded DNA overhang on the DNA origami structure.

4 . The DNA origami structure of claim 1 , further comprising one or more hydrophobic moieties attached to a channel wall inside of the open cavity.

5 . The DNA origami structure of claim 4 , wherein the one or more hydrophobic moieties is covalently attached to a first single-stranded DNA that is hybridized with a first single-stranded DNA overhang inside of the open cavity.

6 . The DNA origami structure of claim 2 , wherein the one or more hydrophobic moieties is cholesterol or tocopherol.

7 . The DNA origami structure of claim 3 , wherein the first single-stranded DNA overhang comprises about 15 to about 30 nucleotides.

8 . The DNA origami structure of claim 1 , further comprising one or more hydrophilic moieties attached to a top portion of the stopper section facing the first end.

9 . The DNA origami structure of claim 8 , wherein each hydrophilic moiety is covalently attached to a second single-stranded DNA that is hybridized with a second single-stranded DNA overhang on the DNA origami structure.

10 . The DNA origami structure of claim 1 , wherein the membrane is a polymer membrane, a lipid membrane, or a solid-state membrane.

11 . The DNA origami structure of claim 1 , wherein the hydrophobic section is about 5 nm to about 100 nm in length.

12 . The DNA origami structure of claim 1 , wherein the stopper section is about 20 nm to about 150 nm in width.

13 . The DNA origami structure of claim 1 , wherein the open cavity is configured to retain a protein nanopore.

14 . The DNA origami structure of claim 13 , wherein the open cavity has a width of about 5 nm to about 15 nm.

15 . The DNA origami structure of claim 1 , wherein the stopper section is about 2 nm to about 20 nm in length.

16 . The DNA origami structure of claim 1 , wherein the DNA origami structure is about 10 nm to about 150 nm in length.

17 . A stable nanopore construct comprises a DNA origami structure of claim 1 and a protein pore immobilized in the open cavity of the DNA origami structure.

18 . The stable nanopore construct of claim 17 , wherein the protein nanopore is covalently linked to the DNA origami structure through thiol modifications, 3′ thiol Modifier C3 S-S, thiol Modifier C6 S-S, 5′ Amino Modifier C6, 5′ Amino Modifier C12, 5′ Dithiol, aziridine modification, Ni-NTA, DBCO/azide.

19 . The stable nanopore construct of claim 17 , wherein the protein nanopore is a MspA pore.

20 . The stable nanopore construct of claim 19 , further comprising a membrane through which the DNA origami structure is inserted.

21 . The stable nanopore construct of claim 20 , wherein the membrane is a polymer membrane, a lipid membrane, or a solid-state membrane.

22 . The stable nanopore construct of claim 21 , wherein the membrane is a solid-state membrane comprising an aperture where the DNA origami structure is inserted through, the aperture has a diameter of about 5 nm to about 100 nm.

23 . A method for determining a sequence of a polynucleotide, the method comprising:

translocating the polynucleotide through a stable nanopore construct of claim 17 under an applied voltage;

measuring current fluctuations as the polynucleotide passes through the stable nanopore construct; and

identify bases of the polynucleotide based on the current fluctuations.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2024
From: GARCIA, MIGUEL ANGEL ALEMAN; RICHEZ, ALEXANDRE
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 067181/0703 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2024
From: ILLUMINA CAMBRIDGE LIMITED
To: ILLUMINA, INC.
Reel/Frame 067186/0583 →